Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 55241-49-1 | MDL No. : | MFCD00772536 |
Formula : | C10H10N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PFRNWHRHGONGPG-UHFFFAOYSA-N |
M.W : | 190.20 | Pubchem ID : | 605450 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 54.11 |
TPSA : | 44.0 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.81 cm/s |
Log Po/w (iLOGP) : | 1.69 |
Log Po/w (XLOGP3) : | 0.92 |
Log Po/w (WLOGP) : | 0.69 |
Log Po/w (MLOGP) : | 0.86 |
Log Po/w (SILICOS-IT) : | 1.11 |
Consensus Log Po/w : | 1.05 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.01 |
Solubility : | 1.86 mg/ml ; 0.00981 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.43 |
Solubility : | 7.07 mg/ml ; 0.0372 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.89 |
Solubility : | 2.43 mg/ml ; 0.0128 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.58 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P270-P280-P305+P351+P338-P264-P301+P312+P330-P501-P337+P313 | UN#: | N/A |
Hazard Statements: | H302-H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In dichloromethane; | A. To a dry flask charged with a stir bar was added 2-(2-amino-ethyl)-isoindole-1,3-dione hydrochloride salt (100 mg, 0.53 mmoles) (Burgess, K.; Ibarzo, J. D.; Linthicum S.; Russell, D. H.; Shin, H.; Shitangkoon, A.; Totani, R.; and Zhang, A.; J. Am. Chem. Soc. 1997, 119, 1556), <strong>[55241-49-1]1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzoimidazole-5-carbaldehyde</strong> (156 mg, 0.68 mmoles), MP-carbonate (254 mg, 0.79 mmoles) (Argonaut Tech), 3 A sieves (1.2 g) and 4 mL of dichloromethane. The flask was sealed with a plastic cap and the resulting mixture was stirred for 48 hours at 22 C. The mixture was filtered through a nylon disk via syringes, rinsing with dichloromethane and the filtrate was concentrated to give 154 mg of 2-{2-[(1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzoimidazol-5-ylmethylene)-amino]-ethyl}-isoindole-1,3-dione as a light yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In butan-1-ol; | 1,3-Dimethyl-5-(2-nitro-propenyl)-1,3-dihydro-benzoimidazol-2-one <strong>[55241-49-1]1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzoimidazole-5-carbaldehyde</strong> (2.48 g, 13.1 mmol, obtained using the same procedure used for 1,3-Diethyl-2-oxo-2,3-dihydro-1H-benzoimidazole-5-carbaldehyde) in n-butanol (25 mL) was treated with -alanine (298.0 mg) and nitroethane (1.85 mL). The mixture was heated to 115 C. for 4 hours, more nitroethane (0.5 mL) was added and the heating was continued for 2 hours. The reaction was allowed to cool, was filtered and washed with ether then dried to give 1,3-Dimethyl-5-(2-nitro-propenyl)-1,3-dihydro-benzoimidazol-2-one (2.229 g). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
at 60.0℃; for 6.0h;Sealed tube; | General procedure: A mixture of an aldehyde (1.0 eq) and an amine (1.0 eq) was heated in a sealed tube at 60 C for 6 h. The crude material was dried under vacuum over phosphorus(V) oxide to give quantitatively the imine which was used in the next step without further purification. |
[ 91350-67-3 ]
1,3,6-Trimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.93
[ 106429-59-8 ]
2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.93
[ 14624-85-2 ]
1,3-Diethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.88
[ 91350-67-3 ]
1,3,6-Trimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.93
[ 106429-59-8 ]
2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.93
[ 14624-85-2 ]
1,3-Diethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.88
[ 19950-97-1 ]
1-Methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid
Similarity: 0.86
[ 863564-77-6 ]
3-Methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid
Similarity: 0.86
[ 91350-67-3 ]
1,3,6-Trimethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.93
[ 106429-59-8 ]
2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.93
[ 14624-85-2 ]
1,3-Diethyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carbaldehyde
Similarity: 0.88
[ 19950-97-1 ]
1-Methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid
Similarity: 0.86
[ 863564-77-6 ]
3-Methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid
Similarity: 0.86